Adhera Therapeutics, Inc.
Adhera Therapeutics, Inc. (ATRX) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · ATRX · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
0
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Adhera Therapeutics, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
ATRX insider buying and selling by quarter
ATRX insider selling · ATRX insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Recent insider transactions
ATRX executive sell shares · ATRX board member insider trading · ATRX insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 1, 2018 | Trieu Vuong Director | Other | 500,000 | $250K | Form 4 |
| Jun 9, 2017 | Trieu Vuong Chairman of the Board · Director | Purchase | 10,000 | $4K | Form 4 |
| Apr 7, 2017 | Ramelli Joseph W. CEO | Purchase | 22,500 | $10K | Form 4 |
| Apr 6, 2017 | Ramelli Joseph W. CEO | Purchase | 13,000 | $4K | Form 4 |
| Apr 5, 2017 | Ramelli Joseph W. CEO | Purchase | 97,550 | $30K | Form 4 |
| Feb 6, 2017 | Trieu Vuong Chairman of the Board · Director | Purchase | 862,068 | $250K | Form 4 |
| Feb 2, 2017 | Ramelli Joseph W. CEO | Award | 100,000 | — | Form 4 |
| Nov 15, 2016 | Trieu Vuong Chairman of the Board · Director | Award | 23,123,558 | — | Form 4 |
| Nov 15, 2016 | Trieu Vuong Chairman of the Board · Director | Award | 11,094,641 | — | Form 4 |
| Nov 15, 2016 | Trieu Vuong Chairman of the Board · Director | Award | 5,255,354 | — | Form 4 |
| Dec 30, 2014 | FRENCH J MICHAEL President and CEO · Director | Other | 309,055 | $102K | Form 4 |
| Jan 1, 2014 | Ramelli Joseph W. Director | Award | 181,303 | $60K | Form 4 |
Trieu Vuong
Chairman of the Board · Director
Date
Jun 9
Shares
10,000
Price
$0.39
Value
$4K
Trieu Vuong
Chairman of the Board · Director
Date
Feb 6
Shares
862,068
Price
$0.29
Value
$250K
Trieu Vuong
Chairman of the Board · Director
Date
Nov 15
Shares
23,123,558
Price
—
Value
—
Trieu Vuong
Chairman of the Board · Director
Date
Nov 15
Shares
11,094,641
Price
—
Value
—
Trieu Vuong
Chairman of the Board · Director
Date
Nov 15
Shares
5,255,354
Price
—
Value
—
FRENCH J MICHAEL
President and CEO · Director
Date
Dec 30
Shares
309,055
Price
$0.33
Value
$102K
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About ATRX insider trading
ATRX insider trades
Adhera Therapeutics, Inc. (ATRX) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including ATRX. Over the past 12 months, 0 insiders have filed transactions with the SEC. ATRX insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Adhera Therapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
ATRX insider trading · 5 questionsThe insiders of Adhera Therapeutics, Inc. (ATRX) include executives and directors such as ATRX, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026